Fundraising Fox
Ryutaro Shimazaki
InvestorPartner at Catalys Pacific
Find your path to Ryutaro
Sign up to see every warm intro you have to Ryutaro
- Paths you didn't know you had: your email and LinkedIn already hold routes to Ryutaro. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Ryutaro is a Partner at Catalys Pacific. He previously served as Executive Officer and Global Head of Nephrology R&D at Kyowa Kirin, where he led the development and regulatory filings of medicines including Darbepoetin alfa, Evocalcet, Pegfilgrastim, and Burosumab, and oversaw more than 10 product launches across Japan and East Asia. He is a graduate of Tokyo University of Science and a qualified pharmacist.
Contact· self-published, not guessed
Invests in
Biotech
Colleagues at Catalys Pacific
Frequently asked questions
- Who is Ryutaro Shimazaki?
- Ryutaro is a Partner at Catalys Pacific. He previously served as Executive Officer and Global Head of Nephrology R&D at Kyowa Kirin, where he led the development and regulatory filings of medicines including Darbepoetin alfa, Evocalcet, Pegfilgrastim, and Burosumab, and oversaw more than 10 product launches across Japan and East Asia. He is a graduate of Tokyo University of Science and a qualified pharmacist.
- Where does Ryutaro Shimazaki work?
- Ryutaro Shimazaki is Partner at Catalys Pacific.
- What does Ryutaro Shimazaki invest in?
- Ryutaro Shimazaki invests in Biotech.
About this profile. Compiled from public sources — Catalys Pacific's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights